fbpx

Tag Archives: SARS-CoV-2

Coronavirus new variant – genomics researcher answers key questions

Kateryna Kon/Shutterstock Lucy van Dorp, UCL A new variant of SARS-CoV-2, the virus which causes COVID-19, is thought to be driving increased transmission of the disease in parts of the UK. The government has placed some regions including London under new, stricter coronavirus restrictions, known as Tier 4. People in Tier 4 areas will not be able to gather with …

Read More »

Keeping indoor air clean can reduce the chance of spreading coronavirus

Open windows and doors to boost air flow and help remove airborne particles. Daniela Torres/EyeEm via Getty Images Shelly Miller, University of Colorado Boulder The vast majority of SARS-CoV-2 transmission occurs indoors, mostly from the inhalation of airborne particles that contain the coronavirus. But in spite of the obvious risks posed by being inside, according to the Centers for Disease …

Read More »

How mRNA vaccines from Pfizer and Moderna work, why they’re a breakthrough and why they need to be kept so cold

Moderna’s new mRNA vaccine is almost 94.5% effective in large-scale trials. JUSTIN TALLIS/AFP via Getty Images Sanjay Mishra, Vanderbilt University As the weather cools, the number of infections of the COVID-19 pandemic are rising sharply. Hamstrung by pandemic fatigue, economic constraints and political discord, public health officials have struggled to control the surging pandemic. But now, a rush of interim …

Read More »

Virus evolution could undermine a COVID-19 vaccine – but this can be stopped

Could SARS-CoV-2 evolve to dodge the vaccine? Jose A. Bernat Bacete/Moment collection/Getty Images Andrew Read, Penn State and David Kennedy, Penn State The first drug against HIV brought dying patients back from the brink. But as excited doctors raced to get the miracle drug to new patients, the miracle melted away. In each and every patient, the drug only worked …

Read More »

What monoclonal antibodies are – and why we need them as well as a vaccine

Y-shaped proteins called antibodies are vital for attacking and destroying the virus. Dr_Microbe/Getty Images Rodney E. Rohde, Texas State University When President Trump was diagnosed with COVID-19, one of the cutting-edge experimental therapies he received was a mixture of monoclonal antibodies. But now a vaccine may soon be available. So are other therapies necessary or valuable? And what exactly is …

Read More »

La vacuna de Pfizer promete, pero faltan datos y su distribución será un desafío

file x ov. niversity of Maryland School of Medicine/AP/AAP Harry Al-Wassiti, Monash University; Colin Pouton, Monash University y Kylie Quinn, RMIT University La empresa de biotecnología alemana BioNTech y la farmacéutica estadounidense Pfizer anunciaron el lunes los primeros resultados prometedores de su ensayo clínico de fase 3 para una vacuna contra el SARS-CoV-2, el virus que causa la covid-19. Estos …

Read More »

A second pathway into cells for SARS-CoV-2: New understanding of the neuropilin-1 protein could speed vaccine research

The Spike protein on the surface of SARS-CoV-2 must bind to proteins on the surface of human cells to trigger an infection. KTSDESIGN/SCIENCE PHOTO LIBRARY/Getty Images Rajesh Khanna, University of Arizona and Aubin Moutal, University of Arizona When it comes to how the coronavirus invades a cell, it takes three to tango. The dance began with the ACE2 receptor, a …

Read More »